Aldebaran Capital »

Kezar Life Sciences shares owned by Aldebaran Capital

Quarter-by-quarter ownership of Kezar Life Sciences (KZR) shares owned by Aldebaran Capital from 13F filings

Historical chart of Aldebaran Capital investment in Kezar Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kezar Life Sciences held by Aldebaran Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kezar Life Sciences by Aldebaran Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $507k 81k 6.29

More positions owned by Aldebaran Capital

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Bunge (BG)
Occidental Petroleum Corporation (OXY)
Bank of America Corporation (BAC)
Ishares Tr Rus Mdcp Val Etf (IWS)
Suncor Energy (SU)
Chevron Corporation (CVX)
JPMorgan Chase & Co. (JPM)
Cato Corp Cl A (CATO)
Aclaris Therapeutics (ACRS)
Abrdn Etfs Bbrg All Comd K1 (BCI)
Freeport-mcmoran CL B (FCX)
Verizon Communications (VZ)

View all positions for Aldebaran Capital

Top funds holding Kezar Life Sciences

BML Capital Management
Suvretta Capital Management
Tang Capital Management
Vanguard Group
Nantahala Capital Management
Affinity Asset Advisors
Stonepine Capital Management
Renaissance Technologies
Peapod Lane Capital
Acadian Asset Management
Susquehanna International
ADAR1 Capital Management
Ikarian Capital
BlackRock
Rangeley Capital

View all funds holding Kezar Life Sciences